TELA Bio (TELA) EBT (2018 - 2026)
TELA Bio's (TELA) quarterly EBT came in at -$12.2 million in Q1 2026, down 8.93% year-on-year from -$13.4 million in Q1 2025, and down 37.29% quarter-over-quarter from -$8.9 million in Q4 2025.
TELA Bio (TELA) EBT (2018 - 2026) Analysis & Trends
TELA Bio's EBT history runs 9 years deep, the most recent figure standing at -$12.2 million for Q1 2026.
- On a quarterly basis, EBT fell 8.93% year-over-year to -$12.2 million in Q1 2026; TTM through Mar 2026 was -$39.6 million, a 702.31% decrease from a year earlier, with the FY2025 full-year figure at -$38.6 million, down 6376.59% from the prior year.
- EBT retreated to -$12.2 million in Q1 2026 per TELA's latest filing, from -$8.9 million in the prior quarter.
- Across five years, EBT topped out at $29.2 million in Q4 2024 and bottomed at -$13.0 million in Q4 2023.
- The 5-year median for EBT is -$11.2 million (2022), against an average of -$8.4 million.
- Across the five-year window, EBT soared 324.95% in 2024 and sank 130.42% in 2025, its largest moves.
- Year by year, EBT stood at -$9.7 million in 2022, then tumbled by 34.47% to -$13.0 million in 2023, then soared by 324.95% to $29.2 million in 2024, then sank by 130.42% to -$8.9 million in 2025, then sank by 37.29% to -$12.2 million in 2026.
- Per Business Quant, the three latest TELA EBT figures stand at -$12.2 million (Q1 2026), -$8.9 million (Q4 2025), and -$8.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 269.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 505.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 222.44 Mn |
| 10 | TELA Bio | 38.36 Mn | -1.18 Mn | 12.52 Mn | -12.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.21 Mn |
| Dec 31, 2025 | -8.90 Mn |
| Sep 30, 2025 | -8.60 Mn |
| Jun 30, 2025 | -9.89 Mn |
| Mar 31, 2025 | -11.21 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | -12.60 Mn |
| Mar 31, 2024 | -5.66 Mn |
| Dec 31, 2023 | -13.00 Mn |
| Sep 30, 2023 | -11.52 Mn |
| Jun 30, 2023 | -12.36 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -9.67 Mn |
| Sep 30, 2022 | -10.69 Mn |
| Jun 30, 2022 | -11.17 Mn |
| Mar 31, 2022 | -11.18 Mn |
| Dec 31, 2021 | -8.55 Mn |
| Sep 30, 2021 | -11.32 Mn |
| Jun 30, 2021 | -14.71 Mn |